Alcobra Announces Second Quarter Financial Results and Provides Corporate Update
August 11, 2014 07:00 ET
|
Alcobra Ltd.
Company Describes New Brain Imaging Data Supporting Use of MDX in ADHD
Company Reviews Patients Demographics in Phase III study
Conference Call & Webcast at 8:30 a.m. Eastern...
Alcobra Releases New Neuroimaging Data Supporting Pro-Cognitive Effects of MDX
August 08, 2014 08:41 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 8, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Provide Corporate Overview at the Canaccord Genuity 34th Annual Growth Conference
August 06, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Release Second Quarter 2014 Results and Host Investor Conference Call and Webcast on Monday, August 11
August 01, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Discusses New Market Research and Updates on Recent Corporate Events at Investor Forum in New York City
July 17, 2014 08:12 ET
|
Alcobra Ltd.
TEL AVIV, Israel, July 17, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Completes Patient Recruitment in Phase III Clinical Trial of MDX in Adult ADHD
July 14, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, July 14, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra to Host Investor Forum and Webcast on July 15 in New York City
July 07, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, July 7, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Provide Corporate Overview at the JMP Securities Healthcare Conference
June 17, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, June 17, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra to Present at the American Society of Clinical Psychopharmacology Annual Meeting and the BIO International Convention
June 09, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, June 9, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Provide Corporate Overview at the Jefferies 2014 Global Healthcare Conference
May 27, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, May 27, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company focused on the development of new medications to help patients with cognitive...